Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Turtle Bear Holdings LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This 1 action represents the current active prosecution for the company. The matter is assigned to 1 distinct art unit, which suggests a specialized technical focus for the pending application within the patent office's organizational structure. This concentration indicates that the company's current intellectual property strategy is focused on 1 technical domain. The 1 pending office action is the sole active matter requiring the company's attention at this time.
The company's prosecution is overseen by 1 distinct examiner. CHEN, CATHERYNE is the busiest examiner for the portfolio, currently handling 1 pending office action. Since this examiner is responsible for 1 pending action, the company's immediate legal strategy in this technology area is focused on the specific requirements and examination style of this 1 official. The success of the pending application relies on addressing the particular feedback provided by this 1 examiner. With only 1 distinct examiner involved, the company can maintain a highly consistent approach to its 1 pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, CATHERYNE | 1 | 37.4% | +18.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18498563 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | CHEN, CATHERYNE | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18498563 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | CHEN, CATHERYNE | 26d |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18498563 | FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION | CHEN, CATHERYNE | 1655 | §102§103§112Other | Non-Final OA | 26d | Pending | Oct 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial